CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Indonesia

Published : Sep-2017

No. of Pages : 150

order by fax Inquire before Buying request discount

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 7
2 Executive Summary 9
3 Introduction 13
3.1 GlobalData Report Guidance 13
4 Overview of the Pharmaceutical and Medical Device Markets 14
4.1 Pharmaceutical Market 14
4.1.1 Market Overview 14
4.1.2 Pharmaceutical Imports and Exports 18
4.1.3 Supply Channels 19
4.1.4 Market Segments 20
4.1.5 Overview Drug Classes 25
4.1.6 Major Players 26
4.2 Medical Device Market 42
4.2.1 Market Overview 42
4.3 Market Drivers and Barriers 42
4.3.1 Drivers 42
4.3.2 Barriers 43
5 Market Access 45
5.1 Reimbursement and Payer Landscape 45
5.1.1 Overview of Healthcare System 45
5.1.2 Drug Classifications 47
5.1.3 Drug Reimbursement Process 48
5.1.4 Overview of Insurance Providers 50
5.1.5 Patient Share in Healthcare Spending 54
5.1.6 Price Trend in Healthcare Services 56
5.1.7 Pricing Policies 56
5.2 Regulatory Landscape 57
5.2.1 Overview of Regulatory Agencies 57
5.2.2 Market Authorization Procedure for New Drugs 59
5.2.3 Market Authorization Procedure for Medical Devices 67
5.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing 70
5.2.5 Licensing Process for Pharmaceutical Exports and Imports 71
5.2.6 Intellectual Property Rights 71
5.2.7 Clinical Trial Regulations 74
5.2.8 Advertising Regulations 76
5.2.9 Pharmacy Regulations 76
5.2.10 Labeling and Packaging Regulations 76
6 Country Analysis 78
6.1 Political Environment 78
6.1.1 Political Structure 78
6.1.2 Analysis of the Current Political Environment 79
6.1.3 Healthcare Policy Initiatives 80
6.2 Economic Landscape 82
6.3 Economic Indicators 85
6.3.1 Gross Domestic Product 85
6.3.2 Gross National Income 89
6.3.3 Inflation 90
6.3.4 Currency Exchange Rate 92
6.3.5 Foreign Direct Investment 93
6.3.6 Foreign Exchange Reserves 94
6.3.7 Trade Balance 95
6.3.8 General Government Structural Balance 97
6.3.9 General Government Gross Debt 98
6.3.10 Major Industries 98
6.4 Demographics 100
6.4.1 Population 100
6.4.2 Urban-Rural Share 102
6.4.3 Distribution by Age Group 103
6.4.4 Birth Rate 105
6.4.5 Mortality 106
6.4.6 Causes of Mortality 107
6.4.7 Health Status by Gender and Age 108
6.4.8 Education and Literacy 114
6.4.9 Employment 116
6.4.10 Disease Burden 116
6.5 Healthcare Infrastructure 118
6.5.1 Healthcare Facilities 118
6.5.2 Healthcare Parameters 121
6.5.3 Environmental Health 121
6.5.4 Healthcare Personnel 124
6.6 Healthcare Expenditure 127
6.6.1 Overview 127
6.6.2 Public-Private Sector Share 128
6.6.3 Major Components of Healthcare Spending 129
6.7 Trade Associations 129
6.7.1 International Pharmaceutical Manufacturers Group 129
6.7.2 Indonesia Pharmaceutical Association 130
6.7.3 Indonesian Medical Association 130
6.8 Trade Fairs 131
7 Opportunities and Challenges 132
7.1 Opportunities 132
7.2 Challenges 132
8 Appendix 134
8.1 Abbreviations 134
8.2 Bibliography 136
8.3 Research Methodology 147
8.3.1 Coverage 147
8.3.2 Secondary Research 147
8.3.3 Forecasts 148
8.3.4 Expert Panel 149
8.4 Contact Us 149
8.5 Disclaimer 149

1.1 List of Tables
Table 1: Pharmaceutical Market, Indonesia, Revenue ($bn), 2009-2016 17
Table 2: Pharmaceutical Market, Indonesia, Revenue Forecast ($bn), 2017-2021 17
Table 3: Pharmaceutical Market, Indonesia, Pharmaceutical Exports and Imports ($bn), 2009-2016 18
Table 4: Pharmaceutical Market, Indonesia, Pharmaceutical Distribution (%), 2014 20
Table 5: Pharmaceutical Market, Indonesia, Unbranded Generics, Revenue ($m), 2009-2015 21
Table 6: Pharmaceutical Market, Indonesia, Unbranded Generics as Percentage of Total Pharmaceutical Market (%), 2009-2015 22
Table 7: Pharmaceutical Market, Indonesia, Over-the-Counter Drug Market Revenue ($bn), 2009-2015 23
Table 8: Pharmaceutical Market, Indonesia, Pharmaceutical Market Share (%), 2009-2015 24
Table 9: Pharmaceutical Market, Kalbe Farma, Indonesia, Major Products, 2016 27
Table 10: Pharmaceutical Market, Tempo Scan, Major Products, 2017 31
Table 11: Pharmaceutical Market, Darya Varia, Major Products, 2017 38
Table 12: Pharmaceutical Market, Indofarma, Major Products, 2017 40
Table 13: Market Access, Indonesia, JKN Coverage Population (million), 2017 53
Table 14: Market Access, Indonesia, Out-of-Pocket Expenditure as Percentage of Total Health Expenditure (%), 2009-2015 55
Table 15: Market Access, Indonesia, Healthcare Inflation (%), 2009-2016 56
Table 16: Economic Indicators, Indonesia, Gross Domestic Product per Capita ($), 2009-2016 85
Table 17: Economic Indicators, Indonesia, Gross Domestic Product per Capita Forecast ($), 2017-2021 86
Table 18: Economic Indicators, Indonesia, Gross Domestic Product Annual Growth (%), 2009-2016 87
Table 19: Economic Indicators, Indonesia, Gross Domestic Product Annual Growth Forecast (%), 2017-2021 88
Table 20: Economic Indicators, Indonesia, Gross National Income per Capita ($), 2009-2016 89
Table 21: Economic Indicators, Indonesia, Average Consumer Price Index, 2009-2016 90
Table 22: Economic Indicators, Indonesia, Average Consumer Price Annual Change (%), 2009-2016 91
Table 23: Economic Indicators, Indonesia, Currency Exchange Rate (IDR per $), 2009-2016 92
Table 24: Economic Indicators, Indonesia, Foreign Direct Investment ($bn), 2009-2016 93
Table 25: Economic Indicators, Indonesia, Foreign Exchange Reserves ($bn), 2009-2016 94
Table 26: Economic Indicators, Indonesia, Imports of Goods and Services ($bn), 2009-2016 95
Table 27: Economic Indicators, Indonesia, Exports of Goods and Services ($bn), 2009-2016 96
Table 28: Economic Indicators, Indonesia, Government Structural Balance ($bn), 2009-2016 97
Table 29: Economic Indicators, Indonesia, General Government Gross Debt ($bn), 2009-2016 98
Table 30: Economic Indicators, Indonesia, Major Industries by Gross Value Added (percentage of GDP), 2016 99
Table 31: Demographics, Indonesia, Population (million), 2009-2016 100
Table 32: Demographics, Indonesia, Population (million), 2017-2021 101
Table 33: Demographics, Indonesia, Urban-Rural Population Share (%), 2009-2016 102
Table 34: Demographics, Indonesia, Population Distribution by Age Group (%), 2009-2016 103
Table 35: Demographics, Indonesia, Population Distribution by Age Group Forecast (%), 2017-2021 104
Table 36: Demographics, Indonesia, Births (per 1,000 population), 2009-2016 105
Table 37: Demographics, Indonesia, Mortality (per 1,000 population), 2009-2015 106
Table 38: Demographics, Indonesia, Major Causes of Mortality (000), 2015 107
Table 39: Demographics, Indonesia, Infant Mortality (per 1,000 live births), 2009-2016 108
Table 40: Demographics, Indonesia, Immunization Rate (%), 2009-2016 109
Table 41: Demographics, Indonesia, Major Causes of Male Mortality (000), 2015 110
Table 42: Demographics, Indonesia, Major Causes of Female Mortality (000), 2015 111
Table 43: Demographics, Indonesia, Gender Ratio (M/F), 2009-2015 112
Table 44: Demographics, Indonesia, Life Expectancy at Birth (years), 2009-2016 113
Table 45: Demographics, Indonesia, Illiteracy by Age Group (%), 2009-2016 114
Table 46: Demographics, Indonesia, School Enrollment by Age Group (%), 2015 115
Table 47: Demographics, Indonesia, Unemployment Rate (%), 2009-2016 116
Table 48: Demographics, Indonesia, Disability-Adjusted Life Years by Major Disease (000), 2015 117
Table 49: Healthcare Infrastructure, Indonesia, Public and Private Hospitals, 2009-2016 118
Table 50: Healthcare Infrastructure, Indonesia, Health Centers (per 30,000 population), 2009-2016 119
Table 51: Healthcare Infrastructure, Indonesia, Share of Hospitals by Type of Care, 2015 120
Table 52: Healthcare Infrastructure, Indonesia, General Hospital Beds (per 1,000 population), 2009-2016 121
Table 53: Healthcare Infrastructure, Indonesia, PM2.5 (µg per m3), 2009-2015 122
Table 54: Healthcare Infrastructure, Indonesia, CO2 Emissions (million metric tons), 2009-2015 123
Table 55: Healthcare Infrastructure, Indonesia, Physicians (per 100,000 population), 2009-2015 124
Table 56: Healthcare Infrastructure, Indonesia, Dentists (per 100,000 population), 2009-2015 125
Table 57: Healthcare Infrastructure, Indonesia, Nurses (per 100,000 population), 2009-2015 126
Table 58: Healthcare Expenditure, Indonesia, Healthcare Expenditure as Percentage of GDP (%), 2009-2015 127
Table 59: Healthcare Expenditure, Indonesia, Public-Private Share (%), 2009-2015 128
Table 60: Healthcare Expenditure, Indonesia, Major Components of Healthcare Spending (%), 2015 129
Table 61: Healthcare Expenditure, Indonesia, Major Healthcare Trade Fairs, 2017 131

1.2 List of Figures
Figure 1: Pharmaceutical Market, Indonesia, Revenue ($bn), 2009-2021 10
Figure 2: Country Profile, Indonesia, 2017 12
Figure 3: Pharmaceutical Market, Indonesia, Revenue ($bn), 2009-2016 16
Figure 4: Pharmaceutical Market, Indonesia, Revenue Forecast ($bn), 2017-2021 17
Figure 5: Pharmaceutical Market, Indonesia, Pharmaceutical Exports and Imports ($bn), 2009-2016 18
Figure 6: Pharmaceutical Market, Indonesia, Distribution Chain, 2014 19
Figure 7: Pharmaceutical Market, Indonesia, Pharmaceutical Distribution (%), 2014 20
Figure 8: Pharmaceutical Market, Indonesia, Unbranded Generics, Revenue ($m), 2009-2015 21
Figure 9: Pharmaceutical Market, Indonesia, Unbranded Generics as Percentage of Total Pharmaceutical Market (%), 2009-2015 22
Figure 10: Pharmaceutical Market, Indonesia, Over-the-Counter Drug Market Revenue ($bn), 2009-2015 23
Figure 11: Pharmaceutical Market, Indonesia, Pharmaceutical Market Share (%), 2009-2015 24
Figure 12: Pharmaceutical Market, Indonesia, Drivers and Barriers, 2017 44
Figure 13: Market Access, Indonesia, Healthcare System, 2017 46
Figure 14: Market Access, Indonesia, History of Health Insurance System, 2017 47
Figure 15: Market Access, Indonesia, Process for Addition to Hospital Drug Formulary, 2015 49
Figure 16: Market Access, Indonesia, Registration Procedure for JKN, 2017 51
Figure 17: Market Access, Indonesia, Members of the JKN, 2017 52
Figure 18: Market Access, Indonesia, Contributions to BPJS, 2017 53
Figure 19: Market Access, Indonesia, Out-of-Pocket Expenditure as Percentage of Total Health Expenditure (%), 2009-2015 55
Figure 20: Market Access, Indonesia, Healthcare Inflation (%), 2009-2016 56
Figure 21: Market Access, Indonesia, Structure of the National Agency of Drug and Food Control, 2017 58
Figure 22: Market Access, Indonesia, New Drug Application Procedure, 2017 60
Figure 23: Market Access, Indonesia, Drug Registration Procedure, 2017 62
Figure 24: Market Access, Indonesia, Drug Evaluation and Decision Making Pathway, 2017 64
Figure 25: Market Access, Indonesia, Regulatory Framework on Ensuring Quality, Safety and Efficacy of Medicine, 2017 65
Figure 26: Market Access, Indonesia, Policy for Biosimilar Product Evaluation, 2017 66
Figure 27: Market Access, Indonesia, General Guidelines on Evaluation of Biosimilar Products, 2017 66
Figure 28: Market Access, Indonesia, Registration of Biosimilar Products, 2017 67
Figure 29: Market Access, Indonesia, Medical Device Approval Process, 2017 70
Figure 30: Market Access, Indonesia, Licensing Process for Manufacturing, 2017 71
Figure 31: Market Access, Indonesia, Structure of the Directorate General of Intellectual Property Office, 2017 72
Figure 32: Market Access, Indonesia, Patent Approval Process, 2017 73
Figure 33: Market Access, Indonesia, Clinical Trial Regulation Process, 2017 75
Figure 34: Economic Indicators, Indonesia, Gross Domestic Product per Capita ($), 2009-2016 85
Figure 35: Economic Indicators, Indonesia, Gross Domestic Product per Capita Forecast ($), 2017-2021 86
Figure 36: Economic Indicators, Indonesia, Gross Domestic Product Annual Growth (%), 2009-2016 87
Figure 37: Economic Indicators, Indonesia, Gross Domestic Product Annual Growth Forecast (%), 2017-2021 88
Figure 38: Economic Indicators, Indonesia, Gross National Income per Capita ($), 2009-2016 89
Figure 39: Economic Indicators, Indonesia, Average Consumer Price Index, 2009-2016 90
Figure 40: Economic Indicators, Indonesia, Average Consumer Price Annual Change (%), 2009-2016 91
Figure 41: Economic Indicators, Indonesia, Currency Exchange Rate (IDR per $), 2009-2016 92
Figure 42: Economic Indicators, Indonesia, Foreign Direct Investment ($bn), 2009-2016 93
Figure 43: Economic Indicators, Indonesia, Foreign Exchange Reserves ($bn), 2009-2016 94
Figure 44: Economic Indicators, Indonesia, Imports of Goods and Services ($bn), 2009-2016 95
Figure 45: Economic Indicators, Indonesia, Exports of Goods and Services ($bn), 2009-2016 96
Figure 46: Economic Indicators, Indonesia, Government Structural Balance ($bn), 2009-2016 97
Figure 47: Economic Indicators, Indonesia, General Government Gross Debt ($bn), 2009-2016 98
Figure 48: Economic Indicators, Indonesia, Major Industries by Gross Value Added (percentage of GDP), 2016 99
Figure 49: Demographics, Indonesia, Population (million), 2009-2016 100
Figure 50: Demographics, Indonesia, Population (million), 2017-2021 101
Figure 51: Demographics, Indonesia, Urban-Rural Population Share (%), 2009-2016 102
Figure 52: Demographics, Indonesia, Population Distribution by Age Group (%), 2009-2016 103
Figure 53: Demographics, Indonesia, Population Distribution by Age Group Forecast (%), 2017-2021 104
Figure 54: Demographics, Indonesia, Births (per 1,000 population), 2009-2016 105
Figure 55: Demographics, Indonesia, Mortality (per 1,000 population), 2009-2015 106
Figure 56: Demographics, Indonesia, Major Causes of Mortality (000), 2015 107
Figure 57: Demographics, Indonesia, Infant Mortality (per 1,000 live births), 2009-2016 108
Figure 58: Demographics, Indonesia, Immunization Rate (%), 2009-2016 109
Figure 59: Demographics, Indonesia, Major Causes of Male Mortality (000), 2015 110
Figure 60: Demographics, Indonesia, Major Causes of Female Mortality (000), 2015 111
Figure 61: Demographics, Indonesia, Gender Ratio (M/F), 2009-2015 112
Figure 62: Demographics, Indonesia, Life Expectancy at Birth (years), 2009-2016 113
Figure 63: Demographics, Indonesia, Illiteracy by Age Group (%), 2009-2016 114
Figure 64: Demographics, Indonesia, School Enrollment by Age Group (%), 2015 115
Figure 65: Demographics, Indonesia, Unemployment Rate (%), 2009-2016 116
Figure 66: Demographics, Indonesia, Disability-Adjusted Life Years by Major Disease (000), 2015 117
Figure 67: Healthcare Infrastructure, Indonesia, Public and Private Hospitals, 2009-2016 118
Figure 68: Healthcare Infrastructure, Indonesia, Health Centers (per 30,000 population), 2009-2016 119
Figure 69: Healthcare Infrastructure, Indonesia, Health Centers (per 100,000 population), 2009-2016 120
Figure 70: Healthcare Infrastructure, Indonesia, General Hospital Beds (per 1,000 population), 2009-2016 121
Figure 71: Healthcare Infrastructure, Indonesia, PM2.5 (µg per m3), 2009-2015 122
Figure 72: Healthcare Infrastructure, Indonesia, CO2 Emissions (million metric tons), 2009-2015 123
Figure 73: Healthcare Infrastructure, Indonesia, Physicians (per 100,000 population), 2009-2015 124
Figure 74: Healthcare Infrastructure, Indonesia, Dentists (per 100,000 population), 2009-2015 125
Figure 75: Healthcare Infrastructure, Indonesia, Nurses (per 100,000 population), 2009-2015 126
Figure 76: Healthcare Expenditure, Indonesia, Healthcare Expenditure as Percentage of GDP (%), 2009-2015 127
Figure 77: Healthcare Expenditure, Indonesia, Public-Private Share (%), 2009-2015 128
Figure 78: Healthcare Expenditure, Indonesia, Major Components of Healthcare Spending (%), 2015 129
Figure 79: Healthcare Market, Indonesia, Opportunities and Challenges, 2017 133

Filed in: Pharmaceutical, Pharmaceuticals and Healthcare

Publisher : GlobalData

Name:
Email:
Phone:
Subject:
Comments:

More Reports

Title	Price	Buy Now
Ambulatory EHR Market by Delivery Mode (Cloud-based, On-premise), Application (e-Prescribing, PHM, Health Analytics, Practice, Patient & Referral Management), Practice Size (Large, Small-to-Medium, Solo), End User (Independent) – Global Forecast to 2027 “The ambulatory EHR market is projected to grow at a CAGR of 6.1% between 2022 and 2027.” The global ambulatory EHR market is projected to reach USD 5.7 billion in 2022 to USD 7.7 billion by 2027, at a CAGR of 6.1%during the forecast period. Growth in this market is driven by the opportunities provided by the market such as increasing demand for cloud-based ambulatory EHR market, and shift towards patient-centric healthcare delivery. However, the interoperability issues & data security concerns are some of the challenges that are expected to limit the growth of the market to a certain extent during the forecast period. “Cloud-based was the fastest-growing segment in the delivery mode of ambulatory EHR market in 2021” Cloud-based segment is projected to growth at the hi......	$4950
Pharmaceutical Excipients Market by Product (Organic Chemicals (Carbohydrates), Inorganic Chemicals (Calcium Phosphate)), Functionality (Fillers, Binders, Lubricants, Preservatives), Formulation (Tablets, Capsules, Parenteral) – Global Forecast to 2027 “The pharmaceutical excipients market growth can be attributed to factors such as the rising pharmaceuticals market, advancements in functional excipients, and the growing generics market. The rapidly growing biopharmaceuticals sector will also influence market growth..” The pharmaceutical excipients market is projected to reach USD 11.5 Billion by 2027 from USD 8.6 Billion in 2022, at a CAGR of 5.9% during the forecast period.The growth can be attributed to the expanding pharmaceutical industry which has fueled the drug production thereby increasing consumption rate for excipients. Additionally, factors like functional excipients development and upsurge in generics market is also likely to propel market growth. “The fillers & diluents functionality accounted for the larges......	$
Digital Pharmacy Market by Drug (Rx, OTC), Product (Medicine, Personal Care, Vitamins & Supplements, Diabetes, CVD, Oncology), Platform (Apps, Websites), Business Model (Captive, Franchise, Aggregator), Geographic (Urban, Rural) – Global Forecasts to 2027 “Digital Pharmacy market to register a CAGR of 17.0% during the forecasts period The digital pharmacy market is expected to reach USD 211.9 billion by 2027 from USD 96.5 billion in 2022, at a CAGR of 17.0% during the forecast period. The growth of this market is driven by the growing consumer preference toward buying online medicines during and post COVID-19 pandemic, consolidation in the market and partnerships, and increasing geriatric population. However, patients relying on pharmacists for clinical support and increasing number of illegal pharmacies are expected to restrain the growth of this market during the forecast period. “Over-the-counter (OTC) products segment is estimated to grow at the highest rate during the forecast period” On the basis ofdrug type, t......	$4950
Pharmacy Automation Market by Product (Automated Medication Dispensing & Storage Systems, Table-Top Counters, Retrieval Systems, Medication Compounding), End User (Inpatient, Outpatient (Fast-Track Clinics), Retail Pharmacies) – Global Forecast to 2027 The pharmacy automation market is expected to grow at a CAGR of 7.9% in the forecast period. The pharmacy automation market is projected to reach USD 8.2 billion by 2027 from USD 5.6 billion in 2022, at a CAGR of 7.9% during the forecast period. The growth in this market is attributed to the growing need to minimize medication errors, rapid decentralization of pharmacies, and growing focus on automation to reduce labor costs. However, the stringent regulations that delay product launches can inhibit the growth of this market. Based on product, the automated medication dispensing and storage systems segment holds the largest market share in 2021 Based on products, the pharmacy automation market is segmented into automated medication dispensing and storage systems, automated packagi......	$4950
Topical Drug Delivery Market by Type (Semi-solids (Creams, Gels, Lotions), Solids(Suppositories), Liquids(Solutions), Transdermal products), Route(Dermal, Ophthalmic), Facility of Use (Homecare setting, Hospitals, Burn Centres) – Global Forecast to 2027 The topical drug delivery market is expected to grow at a CAGR of 8.9% in the forecast period. The global topical drug delivery market is projected to reach USD 317.8 billion by 2027 from USD 207.4 billion in 2022, at a CAGR of 8.9%. The growth of this market can largely be attributed to the high prevalence of topical prescription therapy for dry eye diseases, growing focus of pharmaceutical companies on the R&D of smart transdermal drug delivery systems, increase in prevalence of central nervous disorders, rising preference for non-invasive drug delivery methods. “The semi-solid formulation segment accounted for the largest share of the topical drug delivery market, based on product in 2021.” Based on products, the topical drug delivery the market is segmented into ......	$4950
Cognition and Memory Enhancement Market by Product & Service (Cognition & Memory-enhancing Drugs, Brain-boosting Nutraceuticals, Cognitive Assessment & Training Solutions), Region (North America, Europe, Asia Pacific, ROW) – Global Forecast to 2026 “Increasing incidence and prevalence of neurological disorders is a key factors driving growth in the cognition and memory enhancement market’’ The global cognition and memory enhancement market is projected to reach USD 38.9 billion by 2026 from USD 23.4 billion in 2021, at a CAGR of 10.7% during the forecast period. Elevating prevalence of neurological disorders, such as dementia, epilepsy, Parkinson’s disease, Huntington’s disease, headache disorders, multiple sclerosis, neuroinfections, stroke, and cerebral palsy, have increased significantly over the years. “By product & service segment, the cognition & memory-enhancing drugs segment has registered fastest growth rate during the forecast period” Based on product & service, the cognition and memory en......	$4950
High Potency APIs/HPAPI Market by Type (Innovative, Generic), Type of Synthesis (Synthetic, Biotech, Biosimilars, mAbs, Vaccines), Manufacturers (Captive, Merchant), Application (Oncology, Hormonal Imbalance, Glaucoma) Region – Global forecast to 2027 The HPAPI market is projected to reach USD 39.6 Billion by 2027 from USD 24.5 billion in 2022, at a CAGR of 10.1% from 2022 to 2027. The market is driven by increasing demand for oncology drugs, growing demand for antibody-drug conjugates and others. “The innovative HPAPIs segment is expected to account for the largest share of the market in 2021” Based on type, the HPAPI market is segmented into innovative and generic. The innovative segment is expected to account for the largest share of the HPAPI market in 2021. The large share can be attributed to the increased R&D investments. “The Synthetic APIs segment to account for the largest share of the market in 2021” Based on type of synthesis, the market is segmented into synthetic and biotech HPAPIs. The synthetic AP......	$4950
Plasma Fractionation Market by Product (Immunoglobulins, Albumin, Protease Inhibitors, von Willebrand Factor, PCC), Application (Neurology, Immunology, Hematology, Rheumatology), End User (Clinical Research, Hospitals & Clinics) – Global Forecast to 2027 “Increased risk of communicable diseases, Rising prevalence of bleeding disorders in global population, Use of Immunoglobulin’s for a range of neurological conditions, including multiple sclerosis, neuropathic pain, and chronic fatigue syndrome is expected to drive the overall growth of the plasma fractionation market.” The global plasma fractionation market size is projected to reach USD 36.7 billion by 2027 from USD 26.5 billion in 2022, at a CAGR of 6.7% during the forecast period. Market growth is driven mainly by factors such as rapid growth of geriatric population, growing prevalence of respiratory disorders such as alpha-1-antitrypsin deficiency (AATD) and emphysema, and use of plasma fractionation products as first-line therapies for a number of bleeding, hematological, an......	$4950
Patient Engagement Solutions Market by Component (Software, Services), Delivery (On-Premise, Cloud), Therapy Area (CVD, Diabetes, Obesity, Fitness), Functionality (E-prescribing, Virtual care), End User (Provider, Payer, Patients) – Global Forecast to 2027 “Patient engagement solutions market to register a CAGR of 10.0% from 2022 to 2027” The patient engagement solutions market is projected to reach USD 27.9 billion by 2027 from USD 17.3 billion in 2022, at a CAGR of 10.0% during the forecast period. The growth of this market is driven by the adoption and changes in government regulations to promote patient-centric care and involve patients throughout the care journey, high demand for patient engagement solutions, and the growing utilization of m- health apps. However, interoperability issues for patient engagement solutions and a dreadth of skilled IT professionals in the healthcare industry are expected to restrain the growth of this market during the forecast period. “Services segment is expected to grow at the highest rate......	$4950
Healthcare Cloud Computing Market by Product (EMR/EHR, VNA, RIS, LIS, PIS), Deployment (Private Cloud, Hybrid Cloud, Public Cloud), Component (Software, Services), Pricing (Spot Pricing), Service (SaaS, IaaS, PaaS), End User – Global Forecasts to 2027 The global Healthcare cloud computing market is projected to reach USD 89.4 billion by 2027 from USD 39.4 billion in 2022, at a CAGR of 17.8%. The factors driving the market are adoption of technologies like telehealth, EHR, big data analytics, IoT, cloud computing, m health, wearlable devices, etc. “The healthcare provider solution was the largest segment in the healthcare cloud computing market in 2021.” The healthcare provider segment accounted for the larger share of 79.2% of the healthcare cloud computing market in 2021. The growing adoption of various health IT solutions such as EHR, e-prescribing, telehealth, mHealth, and others due to COVID-19 is one of the key factors contributing to the growth of this segment. “Among end users, the healthcare providers segment ac......	$4950

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Indonesia

Benefits of Sandler Research

User License for Reports

Reach Us

Contact Us

Knowledge Store

Email Subscription

our Feed Reader

Ambulatory EHR Market by Delivery Mode (Cloud-based, On-premise), Application (e-Prescribing, PHM, Health Analytics, Practice, Patient & Referral Management), Practice Size (Large, Small-to-Medium, Solo), End User (Independent) – Global Forecast to 2027

Pharmaceutical Excipients Market by Product (Organic Chemicals (Carbohydrates), Inorganic Chemicals (Calcium Phosphate)), Functionality (Fillers, Binders, Lubricants, Preservatives), Formulation (Tablets, Capsules, Parenteral) – Global Forecast to 2027

Digital Pharmacy Market by Drug (Rx, OTC), Product (Medicine, Personal Care, Vitamins & Supplements, Diabetes, CVD, Oncology), Platform (Apps, Websites), Business Model (Captive, Franchise, Aggregator), Geographic (Urban, Rural) – Global Forecasts to 2027

Pharmacy Automation Market by Product (Automated Medication Dispensing & Storage Systems, Table-Top Counters, Retrieval Systems, Medication Compounding), End User (Inpatient, Outpatient (Fast-Track Clinics), Retail Pharmacies) – Global Forecast to 2027

Topical Drug Delivery Market by Type (Semi-solids (Creams, Gels, Lotions), Solids(Suppositories), Liquids(Solutions), Transdermal products), Route(Dermal, Ophthalmic), Facility of Use (Homecare setting, Hospitals, Burn Centres) – Global Forecast to 2027

Cognition and Memory Enhancement Market by Product & Service (Cognition & Memory-enhancing Drugs, Brain-boosting Nutraceuticals, Cognitive Assessment & Training Solutions), Region (North America, Europe, Asia Pacific, ROW) – Global Forecast to 2026

High Potency APIs/HPAPI Market by Type (Innovative, Generic), Type of Synthesis (Synthetic, Biotech, Biosimilars, mAbs, Vaccines), Manufacturers (Captive, Merchant), Application (Oncology, Hormonal Imbalance, Glaucoma) Region – Global forecast to 2027

Plasma Fractionation Market by Product (Immunoglobulins, Albumin, Protease Inhibitors, von Willebrand Factor, PCC), Application (Neurology, Immunology, Hematology, Rheumatology), End User (Clinical Research, Hospitals & Clinics) – Global Forecast to 2027

Patient Engagement Solutions Market by Component (Software, Services), Delivery (On-Premise, Cloud), Therapy Area (CVD, Diabetes, Obesity, Fitness), Functionality (E-prescribing, Virtual care), End User (Provider, Payer, Patients) – Global Forecast to 2027

Healthcare Cloud Computing Market by Product (EMR/EHR, VNA, RIS, LIS, PIS), Deployment (Private Cloud, Hybrid Cloud, Public Cloud), Component (Software, Services), Pricing (Spot Pricing), Service (SaaS, IaaS, PaaS), End User – Global Forecasts to 2027